reverse

NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to…

1 day ago
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic AlternativesVincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed…

2 weeks ago
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on…

3 weeks ago
Trust Stamp Announces Reverse Stock Split Effective January 6, 2025Trust Stamp Announces Reverse Stock Split Effective January 6, 2025

Trust Stamp Announces Reverse Stock Split Effective January 6, 2025

Atlanta, GA, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), a global provider of AI-powered technologies, has announced…

2 months ago
Optinose Announces 1-for-15 Reverse Stock SplitOptinose Announces 1-for-15 Reverse Stock Split

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by…

3 months ago
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock SplitTransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™…

3 months ago
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock SplitTransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split

BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™…

3 months ago
Silexion Therapeutics Announces 1-for-9 Reverse Share SplitSilexion Therapeutics Announces 1-for-9 Reverse Share Split

Silexion Therapeutics Announces 1-for-9 Reverse Share Split

GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech…

4 months ago
Silexion Therapeutics Announces 1-for-9 Reverse Share SplitSilexion Therapeutics Announces 1-for-9 Reverse Share Split

Silexion Therapeutics Announces 1-for-9 Reverse Share Split

GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech…

4 months ago
Silexion Therapeutics Announces 1-for-9 Reverse Share SplitSilexion Therapeutics Announces 1-for-9 Reverse Share Split

Silexion Therapeutics Announces 1-for-9 Reverse Share Split

GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech…

4 months ago
Show more Posts